ARCT-810
ARCT-810-04
Phase 2 mab active
Quick answer
ARCT-810 for OTC Deficiency is a Phase 2 program (mab) at Arcturus Therapeutics Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcturus Therapeutics Holdings
- Indication
- OTC Deficiency
- Phase
- Phase 2
- Modality
- mab
- Status
- active